Introducing
the Meridian
C. difficile solutions.

For 25 years, we’ve
been proud to work
with healthcare professionals like
you to
build healthier communities and
save lives.

Why our solutions?

We’ll work with you to find the right diagnostic
approach for C. difficile and reduce healthcare costs
associated with isolation, antibiotics and outbreaks.

Focus on
what
really matters.

Working together
to minimize the
impact of C. difficile.

One size
doesn’t fit all.

That’s why we’re the only company to provide a
complete C. difficile testing portfolio. Let’s customize
a diagnostic approach to fit your unique needs.

Swift Response

Increase test sensitivity with this fast one-step solution featuring our illumigene molecular platform.

This one-step solution features our
illumigene molecular platform.

  • Simple, flexible molecular assay for
    C. difficile detection.
  • Results available in 40 minutes.
  • No capital investment, no annual
    maintenance charges.
WANT MORE PRODUCT INFO?
CLICK THE ICON ABOVE.

Agile Response

Combine our illumigene molecular platform with a GDH screen for an effective solution that reduces cost.

This two-step solution features our
ImmunoCard® C. difficile GDH or
PREMIER® C. difficile GDH, plus our
illumigene molecular platform.

  • Screening with a Meridian GDH test has
    shown a sensitivity of up to 100%.*
    *Crobach, M. J. T., et al. “European Society of Clinical Microbiology and Infectious Diseases: Update of the Diagnostic Guidance Document for Clostridium difficile Infection.” Clinical Microbiology and Infection 22 (2016): S63-S81.
  • ImmunoCard® C. difficile GDH
    results available within 30 minutes.
  • Confirm presence of toxigenic
    C. difficile with illumigene.
WANT MORE PRODUCT INFO?
CLICK THE ICONS ABOVE.

Active Response

This two-step solution includes our illumigene molecular platform and C. difficile Toxins A&B tests. Improve performance with DNA testing followed by toxin testing.

This two-step solution features our
ImmunoCard® Toxins A&B or PREMIER®
Toxins A&B plus our illumigene
molecular platform.

  • Detect presence of toxigenic C. difficile
    with illumigene.
  • Confirmation of C. difficile fecal free
    toxins with with ImmunoCard® or
    PREMIER®.
WANT MORE PRODUCT INFO?
CLICK THE ICONS ABOVE.

Total Response

This comprehensive three-step solution features GDH screens, our illumigene molecular platform, and Toxins A&B testing.

This three-step solution features three products
from Meridian's C. difficile testing portfolio:
C. difficile GDH, illumigene and Toxins A&B.

  • The most comprehensive clinical and
    patient management solution.
  • Reduce significant costs by quickly
    eliminating negative results.
  • Flexible second and third steps to meet
    your unique healthcare needs.
WANT MORE PRODUCT INFO?
CLICK THE ICONS ABOVE.

Contact us

Looking forward to hearing from you

To learn more about Meridian and our C. difficile testing portfolio, contact us at 1-888-763-6769 or complete this form. We’ll be in touch soon.